These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 39047011)

  • 1. Correction: Risk factors for critical COVID-19 illness during Delta- and Omicron-predominant period in Korea; using K-COV-N cohort in the National health insurance service.
    Lee KS; Go MJ; Choi YY; Kim MK; Seong J; Sung HK; Jeon J; Jang HC; Kim MH
    PLoS One; 2024; 19(7):e0307925. PubMed ID: 39047011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for critical COVID-19 illness during Delta- and Omicron-predominant period in Korea; using K-COV-N cohort in the National health insurance service.
    Lee KS; Go MJ; Choi YY; Kim MK; Seong J; Sung HK; Jeon J; Jang HC; Kim MH
    PLoS One; 2024; 19(3):e0300306. PubMed ID: 38483919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Characteristics and Outcomes of Children With SARS-CoV-2 Infection During the Delta and Omicron Variant-Dominant Periods in Korea.
    Choi SH; Choi JH; Lee JK; Eun BW; Song SH; Ahn B; Kim YK; Yun KW
    J Korean Med Sci; 2023 Mar; 38(9):e65. PubMed ID: 36880106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Factors for Severe and Critical Coronavirus Disease 2019 in Children.
    Lee KS; Kim YK; Choi YY; Choe YJ; Kim MH; Lee H
    Pediatr Infect Dis J; 2024 Mar; 43(3):234-241. PubMed ID: 38241652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of risk factors for SARS-CoV-2 infection among healthcare workers during Omicron and Delta dominance periods in Japan.
    Li Y; Yamamoto S; Oshiro Y; Inamura N; Nemoto T; Horii K; Takeuchi JS; Mizoue T; Konishi M; Ozeki M; Sugiyama H; Sugiura W; Ohmagari N
    J Hosp Infect; 2023 Apr; 134():97-107. PubMed ID: 36805085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
    Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022.
    Iuliano AD; Brunkard JM; Boehmer TK; Peterson E; Adjei S; Binder AM; Cobb S; Graff P; Hidalgo P; Panaggio MJ; Rainey JJ; Rao P; Soetebier K; Wacaster S; Ai C; Gupta V; Molinari NM; Ritchey MD
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):146-152. PubMed ID: 35085225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19, maternal, and neonatal outcomes: National Mother-Child Cohort (NMCC) of K-COV-N cohort in South Korea.
    Oh J; Lee W; Kim CJ; Kim YJ; Park H; Lee JH; Park MH; Lee S; Ha E; Lee KA
    PLoS One; 2023; 18(4):e0284779. PubMed ID: 37079650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 infection following booster vaccination: Illness and symptom profile in a prospective, observational community-based case-control study.
    Antonelli M; Penfold RS; Canas LDS; Sudre C; Rjoob K; Murray B; Molteni E; Kerfoot E; Cheetham N; Pujol JC; Polidori L; May A; Wolf J; Modat M; Spector T; Hammers A; Ourselin S; Steves C
    J Infect; 2023 Dec; 87(6):506-515. PubMed ID: 37777159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
    Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
    JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics of COVID-19 in hospitalized children during the Omicron variant predominant period.
    Shoji K; Akiyama T; Tsuzuki S; Matsunaga N; Asai Y; Suzuki S; Iwamoto N; Funaki T; Ohmagari N
    J Infect Chemother; 2022 Nov; 28(11):1531-1535. PubMed ID: 35963599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Characteristics and Risk Factors for Mortality in Critical COVID-19 Patients Aged 50 Years or Younger During Omicron Wave in Korea: Comparison With Patients Older Than 50 Years of Age.
    Shi HJ; Yang J; Eom JS; Ko JH; Peck KR; Kim UJ; Jung SI; Kim S; Seok H; Hyun M; Kim HA; Kim B; Joo EJ; Cheong HS; Jun CH; Wi YM; Kim J; Kym S; Lim S; Park Y
    J Korean Med Sci; 2023 Jul; 38(28):e217. PubMed ID: 37463688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction: Prevalence of Gestational Diabetes Mellitus in Korea: A National Health Insurance Database Study.
    Koo BK; Lee JH; Kim J; Jang EJ; Lee CH
    PLoS One; 2016; 11(10):e0165445. PubMed ID: 27764258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Portable Breath-Based Volatile Organic Compound Monitoring for the Detection of COVID-19 During the Circulation of the SARS-CoV-2 Delta Variant and the Transition to the SARS-CoV-2 Omicron Variant.
    Sharma R; Zang W; Tabartehfarahani A; Lam A; Huang X; Sivakumar AD; Thota C; Yang S; Dickson RP; Sjoding MW; Bisco E; Mahmood CC; Diaz KM; Sautter N; Ansari S; Ward KR; Fan X
    JAMA Netw Open; 2023 Feb; 6(2):e230982. PubMed ID: 36853606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Change in Severity and Clinical Manifestation of MIS-C Over SARS-CoV-2 Variant Outbreaks in Korea.
    Choe YJ; Choi EH; Choi JW; Eun BW; Eun LY; Kim YJ; Kim YH; Kim YA; Kim YK; Kwak JH; Lee H; Park JD; Jung YH; Gwack J; Lee S;
    J Korean Med Sci; 2023 Jul; 38(30):e225. PubMed ID: 37527908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute COVID-19 in unvaccinated children without a history of previous infection during the delta and omicron periods.
    Kim JM; Han JY; Han SB
    Postgrad Med; 2023 Sep; 135(7):727-733. PubMed ID: 37585724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between mental illness and COVID-19 susceptibility and clinical outcomes in South Korea: a nationwide cohort study.
    Lee SW; Yang JM; Moon SY; Yoo IK; Ha EK; Kim SY; Park UM; Choi S; Lee SH; Ahn YM; Kim JM; Koh HY; Yon DK
    Lancet Psychiatry; 2020 Dec; 7(12):1025-1031. PubMed ID: 32950066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 disease severity in US Veterans infected during Omicron and Delta variant predominant periods.
    Mayr FB; Talisa VB; Castro AD; Shaikh OS; Omer SB; Butt AA
    Nat Commun; 2022 Jun; 13(1):3647. PubMed ID: 35752687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction: How does it affect service delivery under the National Health Insurance Scheme in Ghana? Health providers and insurance managers perspective on submission and reimbursement of claims.
    Akweongo P; Chatio ST; Owusu R; Salari P; Tediosi F; Aikins M
    PLoS One; 2021; 16(6):e0253357. PubMed ID: 34111214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 Vaccination and Clinical Presentation of COVID-19 in Patients Hospitalized during the Delta- and Omicron-Predominant Periods.
    Stupica D; Collinet-Adler S; Kejžar N; Poljak M; Štamol T
    J Clin Med; 2023 Jan; 12(3):. PubMed ID: 36769609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.